The cost-effectiveness of pulmonary artery catheterization (PAC) has been questioned in many clinical situations. We sought to assess the cost-effectiveness of PAC in patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.
Methods
We constructed a decision analysis model and calculated the incremental cost/quality-adjusted life-year (QALY) saved for hypothetical patients, comparing a PAC strategy to one of no PAC. Sensitivity analyses were performed to test the stability of conclusions over wide ranges of values.
Results
The incremental cost/QALY saved in the cost-effectiveness analysis using baseline data is $77,407 when catheterization-driven therapeutic changes result in a 5% improvement in survival. Cost-effectiveness is sensitive to variations in post-hospital life expectancy, quality of life, and the probability of favorable therapeutic changes resulting from the use of catheterization data.
Conclusions
Pulmonary artery catheterization in COPD exacerbation requiring mechanical ventilation is expensive compared to accepted medical interventions for other conditions, unless changes in therapy prompted by catheterization increase hospital survival to a level 8.7% above baseline. Randomized, controlled trials are needed to investigate the economic impact of PAC and its effect on morbidity and mortality of critically ill patients.
Get full access to this article
View all access options for this article.
References
1.
SchmidtGA, HallJB. Acute or chronic respiratory failure: assessment and management of patients with COPD in the emergency setting. JAMA1989;261(23):3444–3453.
2.
SchusterDP. A physiologic approach to initiating, maintaining, and withdrawing mechanical ventilatory support during acute respiratory failure. Am J Med1990;88(3):268–278.
3.
MatthayMA, ChatterjeeK.Bedside catheterization of the pulmonary artery: risks compared with benefits. Ann Intern Med1988;109(10):826–834.
4.
HudsonLD. Survival data in patients with acute and chronic lung disease requiring mechanical ventilation. Am Rev Respir Dis1989;140(2, Part 2):S19–S24.
5.
SluiterHJ, BlokzijlEJ, van DijlW, van HaeringenJR, HilveringC, SteenhuisEJ. Conservative and respirator treatment of acute respiratory insufficiency in patients with chronic obstructive lung disease: a reappraisal. Am Rev Respir Dis1972;105(6):932–943.
6.
GottliebLS, BalchumOJ. Course of chronic obstructive pulmonary disease following first onset of respiratory failure. Chest1973;63(1):5–8.
7.
MoserKM, ShibelEM, BeamonAJ. Acute respiratory failure in obstructive lung disease: long-term survival after treatment in an intensive care unit. JAMA1973;225(7):705–707.
8.
PettyTL. Intensive and rehabilitative respiratory care, 3rd ed. Philadelphia: Lea & Febiger, 1982:238.
9.
GillespieDJ, MarshHMM, DivertieMB, MeadowsJA3rd. Clinical outcome of respiratory failure in patients requiring prolonged (>24 hours) mechanical ventilation. Chest1986;90(3):364–369.
10.
MenziesR, GibbonsW, GoldbergP.Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest1989;95(2):398–405.
11.
ShachorY, LibermanD, TamirA, SchindlerD, WeilerB, BrudermanI.Long-term survival of patients with chronic obstructive pulmonary disease following mechanical ventilation. Isr J Med Sci1989;25(11):617–619.
12.
PearlmanRA. Variability in physician estimates of survival for acute respiratory failure in chronic obstructive pulmonary disease. Chest1987;91(4):515–521.
13.
ConnorsAFJr, McCaffreeDR, GrayBA. Evaluation of right-heart catheterization in the critically ill patient without acute myocardial infarction. N Engl J Med1983;308(5):263–267.
14.
EisenbergPR, JaffeAS, SchusterDP. Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med1984;12(7):549–553.
15.
BoydKD, ThomasSJ, GoldJ, BoydAD. A prospective study of complications of pulmonary artery catheterizations in 500 consecutive patients. Chest1983;84(3):245–249.
16.
ElliottCG, ZimmermanGA, ClemmerTP. Complications of pulmonary artery catheterization in the care of critically ill patients: a prospective study. Chest1979;76(6):647–652.
17.
SprungCL, JacobsLJ, CaralisPV, KarpfM.Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest1981;79(4):413–415.
18.
FeinAM, GoldbergSK, WalkensteinMD, DershawB, BraitmanL, LippmannML. Is pulmonary artery catheterization necessary for the diagnosis of pulmonary edema?Am Rev Respir Dis1984;129(6):1006–1009.
19.
RobinED. The cult of the Swan-Ganz catheter: overuse and abuse of pulmonary flow catheters. Ann Intern Med1985;103(3):445–449.
SteeleP, EllisJH, VanDykeD, SuttonF, CreaghE, DaviesH.Left ventricular ejection fraction in severe chronic obstructive airways disease. Am J Med1975;59(1):21–28.
22.
PepePE, MariniJJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis1982;126(1):166–170.
23.
GoldenheimPD, KazemiH.Cardiopulmonary monitoring of critically ill patients. N Engl J Med1984;311(12):776–780.
24.
PesceRR. The Swan-Ganz catheter: it goes through your pulmonary artery, and you pay through the nose (editorial). Respir Care1989;34(9):785–788.
25.
BeckJR, PaukerSG, GottliebJE, KleinK, KassirerJP. A convenient approximation of life expectancy (the "DEALE") II. Use in medical decision-making. Am J Med1982;73(6):889–897.
26.
MartinTR, LewisSW, AlbertRK. The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure. Chest1982;82(3):310–314.
27.
SackettDL, TorranceGW. The utility of different health states as perceived by the general public. J Chronic Dis1978;31(11):697–704.
28.
ShoemakerWC, AppelPL, KramHB, WaxmanK, LeeTS. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest1988;94(6):1176–1186.
29.
IbertiTJ, FischerEP, LeibowitzAB, PanacekEA, SilversteinJH, AlbertsonTE, and the Pulmonary Artery Catheter Study Group. A multicenter study of physicians' knowledge of the pulmonary artery catheter. JAMA1990;264(22):2928–2932.
30.
EisenstaedtRS, GetzenTE. Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis. Am J Public Health1988;78(4):450–454.
31.
GoldmanL, SiaST, CookEF, RutherfordJD, WeinsteinMC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med1988;319(3):152–157.
32.
WongJB, SonnenbergFA, SalemDN, PaukerSG. Myocardial revascularization for chronic stable angina: analysis of the role of percutaneous transluminal angioplasty based on data available in 1989. Ann Intern Med1990;113(1):852–871.
33.
StasonWB, WeinsteinMC. Public-health rounds of the Harvard School of Public Health: allocation of resources to manage hypertension. N Engl J Med1977;296(13):732–739.
34.
HayJW, WittelsEH, GottoAMJr. An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. Am J Cardiol1991;67(9):789–796.
35.
NaylorCD, SibbaldWJ, SprungCL, PinfoldSP, CalvinJE, CerraFB. Pulmonary artery catheterization: can there be an integrated strategy for guideline development and research promotion?JAMA1993;269(18):2407–2411.
